Myocardial Energetics in Heart Failure With Preserved Ejection Fraction

被引:39
|
作者
AbouEzzeddine, Omar F. [1 ]
Kemp, Bradley J. [2 ]
Borlaug, Barry A. [1 ]
Mullan, Brian P. [2 ]
Behfar, Atta [1 ]
Pislaru, Sorin V. [1 ]
Fudim, Marat [3 ]
Redfield, Margaret M. [1 ]
Chareonthaitawee, Panithaya [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
[2] Mayo Clin, Dept Radiol, Rochester, MN USA
[3] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
关键词
clinical study; heart failure; hypertrophy; metabolism; positron-emission tomography; physiopathology; EXERCISE INTOLERANCE; OXYGEN-CONSUMPTION; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; BLOOD-FLOW; DYSFUNCTION; RESERVE; RELAXATION; METABOLISM; EFFICIENCY;
D O I
10.1161/CIRCHEARTFAILURE.119.006240
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The role of coronary microvascular disease and its impact on functional and energetic reserve in heart failure with preserved ejection fraction (HFpEF) remains unclear. We hypothesized that in response to submaximal pharmacologic stress (dobutamine), patients with HFpEF have impairment in left ventricular (LV) myocardial mechanical (external work [EW]), energetic (myocardial O-2 consumption [MVO2]), and myocardial blood flow (MBF) reserve. We further assessed whether coupling of MBF to EW is impaired in HFpEF and associated with compensatory increases or pathological decreases in myocardial O-2 extraction. Lastly, we assessed whether coupling of MVO2 to EW (mechanical efficiency) was impaired in HFpEF. Methods and Results: In prospectively enrolled patients with HFpEF (n=19) and age/sex-matched healthy controls (n=19), we performed C-11-acetate positron emission tomography assessing MVO2 and MBF at rest and during dobutamine infusion. EW was calculated as stroke volume (echo)xend-systolic pressurexheart rate. At rest, compared with controls, patients with HFpEF had higher LV EW, MVO2, and MBF. With dobutamine, LV EW, MVO2, and MBF increased in both HFpEF and controls; however, the magnitude of increases was significantly smaller in HFpEF. In both groups, MBF increased in relation to EW, but in HFpEF, the slope of the relationship was significantly smaller than in controls. Myocardial O-2 extraction was increased in HFpEF. Mechanical efficiency was similar in HFpEF and controls. In a post hoc analysis, HFpEF patients with LV hypertrophy (n=10) had significant reductions in LV mechanical efficiency relative to controls. Conclusions: In HFpEF during submaximal dobutamine stress, there is myocardial mechanical-, energetic- and flow-reserve dysfunction with impaired coupling of blood flow to demand and slight increases in myocardial O-2 extraction. These findings provide evidence that coronary microvascular dysfunction is present in HFpEF, limits O-2 supply relative to demand, and is associated with reserve dysfunction.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Myocardial Natriuretic Peptide Expression in Heart Failure With Preserved Ejection Fraction
    Hahn, Virginia S.
    Knutsdottir, Hildur
    Bedi, Kenneth C.
    Margulies, Kenneth B.
    Haldar, Saptarsi M.
    Stolina, Marina
    Bader, Joel S.
    Kass, David A.
    Sharma, Kavita
    CIRCULATION, 2020, 142
  • [42] Myocardial adiposity in heart failure with preserved ejection fraction: the plot thickens
    van Woerden, Gijs
    van Veldhuisen, Dirk J.
    Rienstra, Michiel
    Westenbrink, B. Daan
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (03) : 455 - 457
  • [43] The myocardial flow reserve in patients with heart failure with preserved ejection fraction
    Mochula, Andrew, V
    Kopeva, Kristina, V
    Maltseva, Alina N.
    Grakova, Elena, V
    Gulya, Marina
    Smorgon, Andrey, V
    Gusakova, Anna
    Zavadovsky, Konstantin, V
    HEART AND VESSELS, 2023, 38 (03) : 348 - 360
  • [44] Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
    McDiarmid, Adam K.
    Swoboda, Peter P.
    Erhayiem, Bara
    Bounford, Katrina A.
    Bijsterveld, Petra
    Tyndall, Keith
    Fent, Graham J.
    Garg, Pankaj
    Dobson, Laura E.
    Musa, Tarique A.
    Foley, James R. J.
    Witte, Klaus K.
    Kearney, Mark T.
    Greenwood, John P.
    Plein, Sven
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (01):
  • [45] Age Independent Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
    Mohammed, Selma F.
    Mirzoyev, Sultan A.
    Redfield, Margaret M.
    CIRCULATION, 2012, 126 (21)
  • [46] The myocardial flow reserve in patients with heart failure with preserved ejection fraction
    Andrew V. Mochula
    Kristina V. Kopeva
    Alina N. Maltseva
    Elena V. Grakova
    Marina Gulya
    Andrey V. Smorgon
    Anna Gusakova
    Konstantin V. Zavadovsky
    Heart and Vessels, 2023, 38 : 348 - 360
  • [47] Ongoing myocardial damage in patients with heart failure and preserved ejection fraction
    Kutsuzawa, Daisuke
    Arimoto, Takanori
    Watanabe, Tetsu
    Shishido, Tetsuro
    Miyamoto, Takuya
    Miyashita, Takehiko
    Takahashi, Hiroki
    Niizeki, Takeshi
    Takeishi, Yasuchika
    Kubota, Isao
    JOURNAL OF CARDIOLOGY, 2012, 60 (5-6) : 454 - 461
  • [48] Myocardial hypertrophy and its role in heart failure with preserved ejection fraction
    Heinzel, Frank R.
    Hohendanner, Felix
    Jin, Ge
    Sedej, Simon
    Edelmann, Frank
    JOURNAL OF APPLIED PHYSIOLOGY, 2015, 119 (10) : 1233 - 1242
  • [49] Impaired myocardial work efficiency in heart failure with preserved ejection fraction
    D'Andrea, Antonello
    Ilardi, Federica
    D'Ascenzi, Flavio
    Bandera, Francesco
    Benfari, Giovanni
    Esposito, Roberta
    Malagoli, Alessandro
    Mandoli, Giulia Elena
    Santoro, Ciro
    Russo, Vincenzo
    D'Alto, Michele
    Cameli, Matteo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2021, 22 (11) : 1312 - 1320
  • [50] Myocardial adipose deposition and the development of heart failure with preserved ejection fraction
    Wu, Cho-Kai
    Lee, Jen-Kuang
    Hsu, Jung-Chi
    Su, Mao-Yuan M.
    Wu, Yi-Fan
    Lin, Ting-Tse
    Lan, Chen-Wei
    Hwang, Juey-Jen
    Lin, Lian-Yu
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (03) : 445 - 454